Strategic Expansion Citrus Health Group has recently expanded through the acquisition of The Medicine Group, signaling a growth strategy and appetite for broader market access and medical communications capabilities that can open cross-sell opportunities in CNS therapeutic areas and beyond.

Leadership Strength New leadership hires including a Chief Client Officer and a Chief Medical Officer indicate a focus on client experience, medical strategy, and high-touch engagements, presenting an opening to position premium commercialization and evidence generation services to enterprise pharma clients seeking executive-aligned partnerships.

Integrated Offerings The firm combines commercialization strategy, medical affairs, evidence generation, pricing and market access, and patient support, creating a compelling platform to upsell end-to-end solutions for sponsors needing cohesive, science-driven launch and lifecycle management.

CNS Focus Potential With recent acquisition of a CNS-focused medical communications agency (The Medicine Group), there is a strengthened capability to support CNS asset launches and ongoing CNS evidence dissemination, offering targeted cross-sell to neuroscience portfolios and CNS clinical programs.

Digital & Collaboration Tools Adoption of modern tech stack (iCIMS, AWS, Figma, Smartsheet, collaboration tools) signals scalable operations and efficient client delivery, enabling scalable RFP responses, transparent project management, and data-driven marketing communications for prospective clients seeking agile partners.